Back to All Events

OBN BioTuesday

  • The Petersfield Lecture Theatre Babraham Research Campus CB22 3AT (map)

'What's New in Microbiome Research'

The balance of the gut microbiome has a huge impact on our general well-being and overall health, and this special edition BioTuesday will provide a summary of the latest trends, research and industry thinking about this fascinating topic, including:

  • How new research led by a team at the European Molecular Biology Laboratory (EMBL) in Germany suggests that more than 200 non-antibiotic medicines with human-cell targets, from anti-inflammatory drugs to antipsychotic compounds, can also trigger significant changes in the gut microbiome

  • How microbiome characteristics can predict people’s traits, such as cholesterol levels or obesity

  • How particular microbes and molecular processes help to maintain health in the human microbiome and the link it has to mental and neurological disorders

  • How the balance of the gut microbiome is greatly affected by diet and has the potential to unlock a variety of clinically relevant opportunities

The evening will feature presentations from a range of expert industry experts including:

  • Professor Ian Charles, Director at the Quadram Institute, who specialise in understanding how food and the gut microbiota are linked to the promotion of health and the prevention of disease

  • Professor Glenn Gibson, Head of Food Microbial Sciences at the University of Reading, whose current research includes, chronic gut disease, autism, obesity, gut flora development microbiology, probiotics and prebiotics.

  • Denise Kelly, Microbiome specialist and Venture Partner at Seventure, who finance the development of innovative companies within Life sciences, with a particular focus on the microbiome space

  • Edward Green, CEO at CHAIN Biotechnology who develop Clostridium-based microbial technology for high-value healthcare products

  • Mike Romanos, CEO at Microbiotica – who identify gut bacteria linked to phenotype with unprecedented precision in order to discover and develop live bacterial therapeutics and biomarkers

  • Dmitry Alexeev, RnD Director at Atlas Biomed - Dmitry will share an insight for Atlas Biomed into their 'Listen to Your Gut' Microbiome test where results show how diet affects your gut bacteria